Dr.Fatih YıldırımGeneral Surgery, Medical Aesthetics & Longevity
Heart & Vascular Health

Early detection of silent risks.

Beyond conventional cholesterol values: a cardiovascular risk profile using the coronary calcium score, ApoB, Lp(a), inflammation markers and, where required, advanced imaging.

Program Goals

  • Early detection of atherosclerosis (calcium score)
  • Advanced lipid profile (ApoB, Lp(a))
  • Inflammation panel (HsCRP, IL-6)
  • Blood pressure profiling (24-hour ambulatory)
  • Cardiopulmonary exercise testing (selected cases)
  • Personalized risk management plan

Components

Advanced Lipid Panel

ApoB, LDL-P, Lp(a), HDL-C, triglycerides, oxLDL.

Inflammation Markers

HsCRP, IL-6, homocysteine, fibrinogen.

Metabolic Panel

HbA1c, fasting insulin, HOMA-IR, adiponectin, leptin.

Coronary Calcium Score (CAC)

Degree of coronary artery calcification on low-dose CT — an indicator of early atherosclerosis.

Carotid Ultrasound + IMT

Intima-media thickness of the neck arteries — a very early indicator of atherosclerosis.

24-Hour Ambulatory Blood Pressure

Detection of masked hypertension and the 'non-dipper' pattern.

Protocol Details

Personalization at Dripfy standards.

Each protocol is individually planned after physician evaluation. All applications are made with GMP-grade content and Dripfy GmbH quality standards.

Risk Stratification

Framingham, ASCVD or SCORE2 risk calculations + family history + genetic factors.

Why:

We look at the risk profile as a whole, not at a single value.

Lifestyle Interventions

Mediterranean diet, aerobic exercise, stress management, sleep hygiene — the evidence-based foundation.

Why:

In the ASCVD prevention literature, the strongest interventions are lifestyle-based.

Targeted Drug Therapy (where required)

Statin, ezetimibe, PCSK9 inhibitor — where there is a physician indication.

Why:

In cases of high risk or detected atherosclerosis, pharmacological intervention is evidence-based.

Long-term Follow-up

Panel repeated every 6-12 months, repeat imaging where required.

Why:

Atherosclerosis is a process that unfolds over years — following trends is more valuable than a single measurement.

Process

How We Proceed

1

Cardiology consultation

Family history + current risk factors.

2

Laboratory + imaging

Panel + CAC CT + ambulatory blood pressure.

3

Risk interpretation

Detailed assessment with the physician + plan.

4

Follow-up program

Assessment every 6-12 months.

Timeline

Program Journey

Week 0

Consultation

Medical history + plan.

Weeks 1-2

Panels

Laboratory + imaging.

Week 3

Assessment

Report and plan.

Every 6-12 months

Follow-up

Panel + assessment.

FAQ

Frequently Asked Questions

Scientific Sources

The references below are the literature sources for information on this page. For informational purposes only; treatment decisions are made through face-to-face physician evaluation.

  1. 1.Visseren FLJ, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice — European Heart Journal, 2021. Source

Information: The information on this page is provided for medical education purposes and does not replace a physician consultation. The longevity approaches described are based on current data in the scientific literature; individual results vary from person to person and may not be suitable for everyone. Protocols are personalized after a physician assessment. In line with Dripfy® standards, your health data are processed only with your explicit consent and within the framework of the DSGVO (GDPR).

Personal consultation for this program

Let us listen to your goals and design the right longevity protocol for you.

WhatsAppAppointment Form
WhatsApp